PhaseBio Pharmaceuticals, Inc. (PHAS)
Total Current Liabilities
$24.68M
Quarterly · Period ending: · USD
PHAS Total Current Liabilities
Latest reported$24.68Mperiod ending
Latest reported$24.68Mperiod ending
PHAS Quarterly Current Liabilities ($17.60M → $24.68M)
Quarterly total current liabilities
High-resolution chart · PNG
PHAS total current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Current Liabilities (USD) |
|---|---|
| 24,679,000 | |
| 21,688,000 | |
| 27,883,000 | |
| 21,457,000 | |
| 16,174,000 | |
| 16,668,000 | |
| 14,960,000 | |
| 11,370,000 | |
| 17,802,000 | |
| 7,495,000 | |
| 8,479,000 | |
| 5,962,000 | |
| 5,746,000 | |
| 3,797,000 | |
| 4,577,000 | |
| 7,688,000 | |
| 5,117,000 | |
| 17,595,000 |